Latest Paliperidone Stories
New submission based on positive data from a 15-month schizoaffective relapse prevention study TITUSVILLE, N.J., May 13, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc., today announced
Flood Law Group announced today that it is now available to investigate claims related to complications from taking prescription Invega extended release tablets.
Demonstrated significant efficacy in manic and depressive mood symptoms and psychosis, and improved patient functioning TITUSVILLE, N.J., May 6, 2014 /PRNewswire/ -- Janssen Pharmaceuticals,
First prospective, randomized clinical trial to reflect context of "real world" issues in treating schizophrenia, including recent incarceration and substance abuse TITUSVILLE, N.J.,
TITUSVILLE, N.J., April 22, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc., and Janssen Research and Development, LLC, both members of the Johnson & Johnson Family of Companies, announced that
Study Released as Risperdal Lawsuits Alleging Use of Antipsychotic Drug Caused Gynecomastia (Male Breast Growth) in Men and Boys Continue to Move Forward in Pennsylvania Columbus,
The Firm continues to investigate Risperdal lawsuits that allege the atypical antipsychotic drug caused male breast development, or gynecomastia. New York, New
Independent Data Monitoring Committee Recommends Halting Trial and Unblinding Data Based on Treatment Efficacy TITUSVILLE, N.J., March 20, 2014 /PRNewswire/ -- Janssen Research & Development,
The Agreement Settles Charges that Johnson & Johnson Illegally Marketed Risperdal, Invega and Natracor for Off-Label Use and Paid Kick-Backs to Physicians to Drive Sales of Risperdal and Invega,
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.